532167 — Omkar Pharmachem Balance Sheet
0.000.00%
Last trade - 00:00- IN₹254.10m
- IN₹256.41m
- IN₹5.40m
Annual balance sheet for Omkar Pharmachem, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | PRESS |
| Standards: | IAS | IAS | IAS | IAS | — |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Cash and Short Term Investments | 0.408 | 0.439 | 2.11 | 1.33 | 0.716 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 0.18 | 0.27 | 0.81 | 1.3 | 0.476 |
| Total Other Current Assets | |||||
| Total Current Assets | 0.588 | 0.709 | 2.92 | 2.62 | 1.84 |
| Net Property, Plant And Equipment | 0.025 | 0.015 | 0.064 | 0.037 | 0.081 |
| Long Term Investments | |||||
| Other Long Term Assets | |||||
| Total Assets | 93.6 | 96.3 | 98.3 | 97.3 | 95.9 |
| Accounts Payable | |||||
| Notes Payable / Short Term Debt | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 9.21 | 9.68 | 9.84 | 6.86 | 3.55 |
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 9.21 | 9.68 | 9.84 | 6.86 | 3.6 |
| Common Stock | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Total Equity | 84.4 | 86.6 | 88.5 | 90.4 | 92.3 |
| Total Liabilities & Shareholders' Equity | 93.6 | 96.3 | 98.3 | 97.3 | 95.9 |
| Total Common Shares Outstanding |